Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 62,94
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: California Books, Miami, FL, U.S.A.
EUR 67,61
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 67,39
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 63,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 68,63
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: KS Omniscriptum Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: preigu, Osnabrück, Germania
EUR 52,45
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Medical Management Of Tobacco Associated OPMD | Reeya Garg (u. a.) | Taschenbuch | Englisch | 2025 | KS Omniscriptum Publishing | EAN 9786208443528 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: KS Omniscriptum Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: PBShop.store US, Wood Dale, IL, U.S.A.
EUR 65,33
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Lingua: Inglese
Editore: KS Omniscriptum Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 63,07
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Lingua: Inglese
Editore: Omniscriptum, LAP Lambert Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 60,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Tobacco-associated oral potentially malignant disorders (OPMDs)-including leukoplakia, erythroplakia, proliferative verrucous leukoplakia (PVL), and oral submucous fibrosis (OSMF)-remain a major concern in oral healthcare due to their risk of malignant transformation. Despite numerous treatment modalities, no universally accepted approach exists, emphasizing the need for a multidisciplinary strategy. Early detection, intervention, and tobacco cessation are critical components of management. Pharmacological treatments such as retinoids, beta-carotene, and antifibrotic agents have shown variable success, with no definitive evidence of preventing malignancy. Long-term surveillance, regular follow-ups, and clinical documentation are essential for monitoring disease progression. Challenges include inconsistent diagnostic criteria, lack of high-quality RCTs, and limited treatment efficacy. Future directions should focus on personalized therapies based on genetic markers, regenerative medicine, and public health initiatives targeting tobacco and areca nut use. 120 pp. Englisch.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: CitiRetail, Stevenage, Regno Unito
EUR 68,05
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. Tobacco-associated oral potentially malignant disorders (OPMDs)-including leukoplakia, erythroplakia, proliferative verrucous leukoplakia (PVL), and oral submucous fibrosis (OSMF)-remain a major concern in oral healthcare due to their risk of malignant transformation. Despite numerous treatment modalities, no universally accepted approach exists, emphasizing the need for a multidisciplinary strategy. Early detection, intervention, and tobacco cessation are critical components of management. Pharmacological treatments such as retinoids, beta-carotene, and antifibrotic agents have shown variable success, with no definitive evidence of preventing malignancy. Long-term surveillance, regular follow-ups, and clinical documentation are essential for monitoring disease progression. Challenges include inconsistent diagnostic criteria, lack of high-quality RCTs, and limited treatment efficacy. Future directions should focus on personalized therapies based on genetic markers, regenerative medicine, and public health initiatives targeting tobacco and areca nut use. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: Majestic Books, Hounslow, Regno Unito
EUR 110,92
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. Print on Demand.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 110,33
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Lingua: Inglese
Editore: KS Omniscriptum Publishing, 2025
ISBN 10: 6208443520 ISBN 13: 9786208443528
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 61,63
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Tobacco-associated oral potentially malignant disorders (OPMDs)-including leukoplakia, erythroplakia, proliferative verrucous leukoplakia (PVL), and oral submucous fibrosis (OSMF)-remain a major concern in oral healthcare due to their risk of malignant transformation. Despite numerous treatment modalities, no universally accepted approach exists, emphasizing the need for a multidisciplinary strategy. Early detection, intervention, and tobacco cessation are critical components of management. Pharmacological treatments such as retinoids, beta-carotene, and antifibrotic agents have shown variable success, with no definitive evidence of preventing malignancy. Long-term surveillance, regular follow-ups, and clinical documentation are essential for monitoring disease progression. Challenges include inconsistent diagnostic criteria, lack of high-quality RCTs, and limited treatment efficacy. Future directions should focus on personalized therapies based on genetic markers, regenerative medicine, and public health initiatives targeting tobacco and areca nut use.